Precigen, Inc. EV/Sales

EV/Sales of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/Sales growth rates and interactive chart. Compares the total enterprise value of a company to its sales. It is a more accurate measure of business value, as it takes into account cash and debt on the balance sheet. A company with large cash holdings and no debt will show a significantly lower EV/S than P/S ratio.


Highlights and Quick Summary

Current EV/Sales of Precigen, Inc. is 7.88 (as of December 31, 2021)
  • EV/Sales for the quarter ending March 31, 2022 was 4.68 (a -40.55% decrease compared to previous quarter)
  • Year-over-year quarterly EV/Sales decreased by -65.56%
  • Annual EV/Sales for 2021 was 7.88 (a -54.23% decrease from previous year)
  • Annual EV/Sales for 2020 was 17.21 (a 58.1% increase from previous year)
  • Annual EV/Sales for 2019 was 10.89 (a 97.03% increase from previous year)
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/Sales of Precigen, Inc.

Most recent EV/Salesof PGEN including historical data for past 10 years.

Interactive Chart of EV/Sales of Precigen, Inc.

Precigen, Inc. EV/Sales for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 4.68
2021 7.88 10.84 13.6 14.43 7.88
2020 17.21 6.55 9.51 6.29 17.21
2019 10.89 9.4 10.25 6.35 10.89
2018 5.53 11.08 8.68 8.8 5.53
2017 7.03 11.15 13.43 10.7 7.03
2016 14.09 16.53 13.86 20.24 14.09
2015 17.97 20.6 39.52 47.41 17.97
2014 36.49 36.34 70.43 84.31 36.49
2013 33.63 55.83 0.78 0.78 33.63
2012 0.78 0.78 0.78
2011 0.78

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology